Treatment Patterns, Glycemic Control & Bodyweight With Canagliflozin 300 Mg Versus GLP1RAs in Type II Diabetes Patients
Journal of Comparative Effectiveness Research - United Kingdom
doi 10.2217/cer-2019-0002
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2019
Authors
Publisher
Future Medicine Ltd